nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—CYP2C9—brain cancer	0.643	1	CbGaD
Brompheniramine—CYP2D6—Lomustine—brain cancer	0.067	0.239	CbGbCtD
Brompheniramine—CYP2D6—Hydroxyurea—brain cancer	0.0508	0.181	CbGbCtD
Brompheniramine—CYP3A4—Temozolomide—brain cancer	0.0501	0.179	CbGbCtD
Brompheniramine—CYP3A4—Lomustine—brain cancer	0.0426	0.152	CbGbCtD
Brompheniramine—CYP2E1—Etoposide—brain cancer	0.034	0.121	CbGbCtD
Brompheniramine—CYP2C8—Etoposide—brain cancer	0.0254	0.0906	CbGbCtD
Brompheniramine—CYP3A4—Etoposide—brain cancer	0.0103	0.0367	CbGbCtD
Brompheniramine—HRH1—nose—brain cancer	0.00251	0.143	CbGeAlD
Brompheniramine—Tolterodine—CYP2C9—brain cancer	0.00079	0.36	CrCbGaD
Brompheniramine—Carbinoxamine—CYP2C9—brain cancer	0.000678	0.309	CrCbGaD
Brompheniramine—CHRM4—head—brain cancer	0.000549	0.0314	CbGeAlD
Brompheniramine—CHRM4—central nervous system—brain cancer	0.000501	0.0286	CbGeAlD
Brompheniramine—CHRM2—telencephalon—brain cancer	0.000473	0.027	CbGeAlD
Brompheniramine—CHRM1—telencephalon—brain cancer	0.00043	0.0246	CbGeAlD
Brompheniramine—CHRM5—head—brain cancer	0.000429	0.0245	CbGeAlD
Brompheniramine—CYP2D6—hindbrain—brain cancer	0.000409	0.0234	CbGeAlD
Brompheniramine—CHRM4—brain—brain cancer	0.000398	0.0227	CbGeAlD
Brompheniramine—CHRM5—central nervous system—brain cancer	0.000391	0.0224	CbGeAlD
Brompheniramine—Diphenhydramine—CYP2C9—brain cancer	0.000391	0.178	CrCbGaD
Brompheniramine—CHRM3—telencephalon—brain cancer	0.000385	0.022	CbGeAlD
Brompheniramine—KCNH2—telencephalon—brain cancer	0.000341	0.0195	CbGeAlD
Brompheniramine—Promazine—CYP2C9—brain cancer	0.000337	0.154	CrCbGaD
Brompheniramine—CHRM5—brain—brain cancer	0.000311	0.0178	CbGeAlD
Brompheniramine—CHRM2—endocrine gland—brain cancer	0.000298	0.017	CbGeAlD
Brompheniramine—CHRM2—head—brain cancer	0.000294	0.0168	CbGeAlD
Brompheniramine—KCNH2—pituitary gland—brain cancer	0.000278	0.0159	CbGeAlD
Brompheniramine—HRH1—telencephalon—brain cancer	0.000274	0.0156	CbGeAlD
Brompheniramine—CHRM1—endocrine gland—brain cancer	0.000271	0.0155	CbGeAlD
Brompheniramine—CHRM2—central nervous system—brain cancer	0.000269	0.0154	CbGeAlD
Brompheniramine—KCNH2—medulla oblongata—brain cancer	0.000268	0.0153	CbGeAlD
Brompheniramine—CHRM1—head—brain cancer	0.000268	0.0153	CbGeAlD
Brompheniramine—CYP2E1—telencephalon—brain cancer	0.000263	0.015	CbGeAlD
Brompheniramine—CYP2C8—pituitary gland—brain cancer	0.000254	0.0145	CbGeAlD
Brompheniramine—KCNH2—midbrain—brain cancer	0.000245	0.014	CbGeAlD
Brompheniramine—CHRM1—central nervous system—brain cancer	0.000245	0.014	CbGeAlD
Brompheniramine—CHRM3—endocrine gland—brain cancer	0.000243	0.0139	CbGeAlD
Brompheniramine—CHRM3—head—brain cancer	0.00024	0.0137	CbGeAlD
Brompheniramine—KCNH2—spinal cord—brain cancer	0.000239	0.0137	CbGeAlD
Brompheniramine—CYP2D6—brainstem—brain cancer	0.000235	0.0134	CbGeAlD
Brompheniramine—CYP2B6—gonad—brain cancer	0.000234	0.0134	CbGeAlD
Brompheniramine—CYP2C19—endocrine gland—brain cancer	0.000226	0.0129	CbGeAlD
Brompheniramine—CHRM3—central nervous system—brain cancer	0.000219	0.0125	CbGeAlD
Brompheniramine—KCNH2—endocrine gland—brain cancer	0.000215	0.0123	CbGeAlD
Brompheniramine—CHRM2—brain—brain cancer	0.000213	0.0122	CbGeAlD
Brompheniramine—KCNH2—head—brain cancer	0.000213	0.0122	CbGeAlD
Brompheniramine—CYP2D6—telencephalon—brain cancer	0.000208	0.0119	CbGeAlD
Brompheniramine—CYP2E1—medulla oblongata—brain cancer	0.000207	0.0118	CbGeAlD
Brompheniramine—CYP2C8—endocrine gland—brain cancer	0.000197	0.0113	CbGeAlD
Brompheniramine—CHRM1—brain—brain cancer	0.000194	0.0111	CbGeAlD
Brompheniramine—KCNH2—central nervous system—brain cancer	0.000194	0.0111	CbGeAlD
Brompheniramine—KCNH2—cerebellum—brain cancer	0.00019	0.0108	CbGeAlD
Brompheniramine—CYP2E1—spinal cord—brain cancer	0.000184	0.0105	CbGeAlD
Brompheniramine—CYP2B6—endocrine gland—brain cancer	0.000177	0.0101	CbGeAlD
Brompheniramine—CYP2C9—endocrine gland—brain cancer	0.000175	0.01	CbGeAlD
Brompheniramine—CYP2B6—head—brain cancer	0.000174	0.00997	CbGeAlD
Brompheniramine—CHRM3—brain—brain cancer	0.000174	0.00993	CbGeAlD
Brompheniramine—HRH1—endocrine gland—brain cancer	0.000173	0.00987	CbGeAlD
Brompheniramine—HRH1—head—brain cancer	0.00017	0.00974	CbGeAlD
Brompheniramine—CYP2E1—endocrine gland—brain cancer	0.000166	0.00948	CbGeAlD
Brompheniramine—CYP2E1—head—brain cancer	0.000164	0.00936	CbGeAlD
Brompheniramine—CYP2B6—central nervous system—brain cancer	0.000159	0.0091	CbGeAlD
Brompheniramine—HRH1—central nervous system—brain cancer	0.000156	0.00889	CbGeAlD
Brompheniramine—KCNH2—brain—brain cancer	0.000154	0.00881	CbGeAlD
Brompheniramine—CYP2E1—central nervous system—brain cancer	0.000149	0.00854	CbGeAlD
Brompheniramine—CYP2E1—cerebellum—brain cancer	0.000146	0.00835	CbGeAlD
Brompheniramine—CYP2C8—brain—brain cancer	0.000141	0.00806	CbGeAlD
Brompheniramine—CYP3A4—endocrine gland—brain cancer	0.000133	0.00763	CbGeAlD
Brompheniramine—CYP2D6—endocrine gland—brain cancer	0.000131	0.00751	CbGeAlD
Brompheniramine—CYP2D6—head—brain cancer	0.00013	0.00741	CbGeAlD
Brompheniramine—CYP2B6—brain—brain cancer	0.000126	0.00723	CbGeAlD
Brompheniramine—HRH1—brain—brain cancer	0.000123	0.00706	CbGeAlD
Brompheniramine—CYP3A4—central nervous system—brain cancer	0.00012	0.00687	CbGeAlD
Brompheniramine—CYP2E1—brain—brain cancer	0.000119	0.00678	CbGeAlD
Brompheniramine—CYP2D6—central nervous system—brain cancer	0.000118	0.00677	CbGeAlD
Brompheniramine—CYP2D6—cerebellum—brain cancer	0.000116	0.00661	CbGeAlD
Brompheniramine—CYP2D6—brain—brain cancer	9.39e-05	0.00537	CbGeAlD
Brompheniramine—CHRM3—Signaling by GPCR—TRPC6—brain cancer	2.81e-05	0.000492	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—TRPC6—brain cancer	2.78e-05	0.000487	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—PTCH1—brain cancer	2.78e-05	0.000487	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—SMO—brain cancer	2.78e-05	0.000487	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—PTCH1—brain cancer	2.77e-05	0.000485	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—SMO—brain cancer	2.77e-05	0.000485	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—SMO—brain cancer	2.76e-05	0.000484	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—PTCH1—brain cancer	2.76e-05	0.000484	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—SMO—brain cancer	2.73e-05	0.000479	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—PTCH1—brain cancer	2.73e-05	0.000479	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ABR—brain cancer	2.64e-05	0.000462	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ABR—brain cancer	2.63e-05	0.00046	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ABR—brain cancer	2.62e-05	0.000459	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—BSG—brain cancer	2.6e-05	0.000456	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—IDH1—brain cancer	2.6e-05	0.000456	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ABR—brain cancer	2.59e-05	0.000455	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CYP2C9—brain cancer	2.59e-05	0.000454	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—SHH—brain cancer	2.56e-05	0.000448	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—BSG—brain cancer	2.55e-05	0.000447	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—GLI2—brain cancer	2.55e-05	0.000446	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—GLI2—brain cancer	2.54e-05	0.000445	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—GLI2—brain cancer	2.53e-05	0.000443	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—GLI2—brain cancer	2.5e-05	0.000439	CbGpPWpGaD
Brompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	2.5e-05	0.000438	CbGpPWpGaD
Brompheniramine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	2.49e-05	0.000437	CbGpPWpGaD
Brompheniramine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	2.48e-05	0.000435	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TRPC6—brain cancer	2.47e-05	0.000432	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—SHH—brain cancer	2.45e-05	0.000429	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—PTCH1—brain cancer	2.42e-05	0.000425	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—SMO—brain cancer	2.42e-05	0.000425	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—GLI1—brain cancer	2.39e-05	0.000419	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—GLI1—brain cancer	2.39e-05	0.000418	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—GLI1—brain cancer	2.38e-05	0.000417	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TRPC6—brain cancer	2.36e-05	0.000414	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—GLI1—brain cancer	2.35e-05	0.000413	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—VAV1—brain cancer	2.33e-05	0.000408	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—VAV1—brain cancer	2.32e-05	0.000407	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—PTCH1—brain cancer	2.32e-05	0.000407	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—SMO—brain cancer	2.32e-05	0.000407	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—VAV1—brain cancer	2.32e-05	0.000406	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CYP2C9—brain cancer	2.31e-05	0.000405	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—VAV1—brain cancer	2.29e-05	0.000402	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SUFU—brain cancer	2.27e-05	0.000398	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SUFU—brain cancer	2.26e-05	0.000396	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SUFU—brain cancer	2.25e-05	0.000395	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—IDH1—brain cancer	2.24e-05	0.000392	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SUFU—brain cancer	2.23e-05	0.000391	CbGpPWpGaD
Brompheniramine—CHRM1—Circadian rythm related genes—TP53—brain cancer	2.21e-05	0.000387	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—BSG—brain cancer	2.2e-05	0.000386	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—IDH1—brain cancer	2.19e-05	0.000384	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—GFAP—brain cancer	2.19e-05	0.000384	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—PIK3CG—brain cancer	2.19e-05	0.000383	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—GFAP—brain cancer	2.18e-05	0.000382	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—GFAP—brain cancer	2.17e-05	0.000381	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—GFAP—brain cancer	2.15e-05	0.000378	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CYP2C9—brain cancer	2.13e-05	0.000373	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—VAV1—brain cancer	2.12e-05	0.000371	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—VAV1—brain cancer	2.11e-05	0.00037	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—VAV1—brain cancer	2.1e-05	0.000369	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—PIK3CG—brain cancer	2.09e-05	0.000367	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—VAV1—brain cancer	2.08e-05	0.000365	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HEY1—brain cancer	2.08e-05	0.000364	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HEY1—brain cancer	2.07e-05	0.000363	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HEY1—brain cancer	2.06e-05	0.000361	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—ENO2—brain cancer	2.06e-05	0.00036	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HEY1—brain cancer	2.04e-05	0.000358	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—DLL1—brain cancer	2.03e-05	0.000357	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—DLL1—brain cancer	2.03e-05	0.000356	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—DLL1—brain cancer	2.02e-05	0.000354	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—DLL1—brain cancer	2e-05	0.000351	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—PIK3CG—brain cancer	1.99e-05	0.000348	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—BSG—brain cancer	1.97e-05	0.000345	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NOTCH2—brain cancer	1.94e-05	0.00034	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—PIK3CG—brain cancer	1.9e-05	0.000333	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—IDH1—brain cancer	1.89e-05	0.000332	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NOTCH2—brain cancer	1.86e-05	0.000325	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—VAV1—brain cancer	1.85e-05	0.000324	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—BSG—brain cancer	1.81e-05	0.000317	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—BSG—brain cancer	1.79e-05	0.000314	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—VAV1—brain cancer	1.77e-05	0.00031	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—ENO2—brain cancer	1.77e-05	0.00031	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—ENO2—brain cancer	1.73e-05	0.000304	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SHH—brain cancer	1.73e-05	0.000303	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SHH—brain cancer	1.72e-05	0.000302	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SHH—brain cancer	1.72e-05	0.000301	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SHH—brain cancer	1.7e-05	0.000298	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—IDH1—brain cancer	1.69e-05	0.000296	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TRPC6—brain cancer	1.67e-05	0.000292	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TRPC6—brain cancer	1.66e-05	0.000291	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TRPC6—brain cancer	1.66e-05	0.000291	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TRPC6—brain cancer	1.64e-05	0.000288	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PTCH1—brain cancer	1.64e-05	0.000287	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SMO—brain cancer	1.64e-05	0.000287	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PTCH1—brain cancer	1.63e-05	0.000287	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SMO—brain cancer	1.63e-05	0.000287	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PTCH1—brain cancer	1.63e-05	0.000286	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SMO—brain cancer	1.63e-05	0.000286	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PTCH1—brain cancer	1.61e-05	0.000283	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SMO—brain cancer	1.61e-05	0.000283	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—HES1—brain cancer	1.59e-05	0.000279	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—IDH1—brain cancer	1.56e-05	0.000273	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.54e-05	0.00027	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—IDH1—brain cancer	1.54e-05	0.00027	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—IL2—brain cancer	1.54e-05	0.00027	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—HES1—brain cancer	1.52e-05	0.000267	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—PDGFRA—brain cancer	1.51e-05	0.000265	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ENO2—brain cancer	1.5e-05	0.000262	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—PIK3CG—brain cancer	1.48e-05	0.000259	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—PIK3CG—brain cancer	1.47e-05	0.000259	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—IL2—brain cancer	1.47e-05	0.000258	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—PIK3CG—brain cancer	1.47e-05	0.000258	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—SPP1—brain cancer	1.47e-05	0.000257	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—PIK3CG—brain cancer	1.46e-05	0.000255	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—PDGFRA—brain cancer	1.45e-05	0.000254	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—SPP1—brain cancer	1.41e-05	0.000247	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—IL2—brain cancer	1.4e-05	0.000245	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP2C9—brain cancer	1.39e-05	0.000244	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.38e-05	0.000241	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—PIK3CG—brain cancer	1.34e-05	0.000236	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—PIK3CG—brain cancer	1.34e-05	0.000235	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—IL2—brain cancer	1.34e-05	0.000235	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ENO2—brain cancer	1.34e-05	0.000234	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—PIK3CG—brain cancer	1.34e-05	0.000234	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IRS2—brain cancer	1.33e-05	0.000233	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—PIK3CG—brain cancer	1.32e-05	0.000232	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NOTCH2—brain cancer	1.31e-05	0.00023	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NOTCH2—brain cancer	1.31e-05	0.000229	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NOTCH2—brain cancer	1.3e-05	0.000228	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NOTCH2—brain cancer	1.29e-05	0.000226	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IRS2—brain cancer	1.27e-05	0.000223	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.26e-05	0.00022	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—VAV1—brain cancer	1.25e-05	0.000219	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—VAV1—brain cancer	1.25e-05	0.000218	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—VAV1—brain cancer	1.24e-05	0.000218	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—VAV1—brain cancer	1.23e-05	0.000216	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ENO2—brain cancer	1.23e-05	0.000215	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ENO2—brain cancer	1.22e-05	0.000214	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—BSG—brain cancer	1.18e-05	0.000207	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—APC—brain cancer	1.17e-05	0.000206	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—PIK3CG—brain cancer	1.17e-05	0.000206	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—APC—brain cancer	1.12e-05	0.000197	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—PIK3CG—brain cancer	1.12e-05	0.000197	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HES1—brain cancer	1.08e-05	0.000188	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HES1—brain cancer	1.07e-05	0.000188	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—EGFR—brain cancer	1.07e-05	0.000187	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HES1—brain cancer	1.07e-05	0.000187	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HES1—brain cancer	1.06e-05	0.000185	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—IL2—brain cancer	1.04e-05	0.000183	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—IL2—brain cancer	1.04e-05	0.000182	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—IL2—brain cancer	1.03e-05	0.000181	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—IL2—brain cancer	1.02e-05	0.00018	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—EGFR—brain cancer	1.02e-05	0.000179	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PDGFRA—brain cancer	1.02e-05	0.000179	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PDGFRA—brain cancer	1.02e-05	0.000179	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PDGFRA—brain cancer	1.02e-05	0.000178	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—IDH1—brain cancer	1.02e-05	0.000178	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PDGFRA—brain cancer	1.01e-05	0.000177	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SPP1—brain cancer	9.94e-06	0.000174	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SPP1—brain cancer	9.91e-06	0.000174	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SPP1—brain cancer	9.87e-06	0.000173	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SPP1—brain cancer	9.78e-06	0.000171	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL2—brain cancer	9.46e-06	0.000166	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PIK3CG—brain cancer	9.43e-06	0.000165	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL2—brain cancer	9.42e-06	0.000165	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL2—brain cancer	9.4e-06	0.000165	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL2—brain cancer	9.3e-06	0.000163	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—RELA—brain cancer	9.17e-06	0.000161	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—ERBB2—brain cancer	9.11e-06	0.00016	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IRS2—brain cancer	8.99e-06	0.000158	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IRS2—brain cancer	8.96e-06	0.000157	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IRS2—brain cancer	8.93e-06	0.000157	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IRS2—brain cancer	8.84e-06	0.000155	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—RELA—brain cancer	8.78e-06	0.000154	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—ERBB2—brain cancer	8.72e-06	0.000153	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL2—brain cancer	8.26e-06	0.000145	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PIK3CG—brain cancer	8.11e-06	0.000142	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CCND1—brain cancer	8.05e-06	0.000141	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ENO2—brain cancer	8.04e-06	0.000141	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CTNNB1—brain cancer	7.97e-06	0.00014	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PIK3CG—brain cancer	7.95e-06	0.000139	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—APC—brain cancer	7.94e-06	0.000139	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PIK3CG—brain cancer	7.94e-06	0.000139	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PIK3CG—brain cancer	7.91e-06	0.000139	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—APC—brain cancer	7.91e-06	0.000139	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL2—brain cancer	7.91e-06	0.000139	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PIK3CG—brain cancer	7.89e-06	0.000138	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—APC—brain cancer	7.89e-06	0.000138	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—APC—brain cancer	7.81e-06	0.000137	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PIK3CG—brain cancer	7.81e-06	0.000137	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CCND1—brain cancer	7.71e-06	0.000135	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CTNNB1—brain cancer	7.63e-06	0.000134	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—EGFR—brain cancer	7.23e-06	0.000127	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—EGFR—brain cancer	7.21e-06	0.000126	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—EGFR—brain cancer	7.19e-06	0.000126	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—EGFR—brain cancer	7.12e-06	0.000125	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—VEGFA—brain cancer	7.02e-06	0.000123	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—STAT3—brain cancer	6.95e-06	0.000122	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3CG—brain cancer	6.87e-06	0.00012	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—VEGFA—brain cancer	6.72e-06	0.000118	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—STAT3—brain cancer	6.65e-06	0.000117	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MYC—brain cancer	6.46e-06	0.000113	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—EGFR—brain cancer	6.32e-06	0.000111	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—RELA—brain cancer	6.2e-06	0.000109	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MYC—brain cancer	6.18e-06	0.000108	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—RELA—brain cancer	6.18e-06	0.000108	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ERBB2—brain cancer	6.16e-06	0.000108	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—RELA—brain cancer	6.16e-06	0.000108	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ERBB2—brain cancer	6.14e-06	0.000108	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CG—brain cancer	6.13e-06	0.000107	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ERBB2—brain cancer	6.12e-06	0.000107	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—RELA—brain cancer	6.1e-06	0.000107	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ERBB2—brain cancer	6.06e-06	0.000106	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—EGFR—brain cancer	6.05e-06	0.000106	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CG—brain cancer	5.64e-06	9.88e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CG—brain cancer	5.59e-06	9.8e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL2—brain cancer	5.59e-06	9.79e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL2—brain cancer	5.57e-06	9.76e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL2—brain cancer	5.55e-06	9.73e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL2—brain cancer	5.5e-06	9.63e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCND1—brain cancer	5.45e-06	9.54e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCND1—brain cancer	5.43e-06	9.51e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCND1—brain cancer	5.41e-06	9.48e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CTNNB1—brain cancer	5.39e-06	9.45e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CTNNB1—brain cancer	5.37e-06	9.42e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCND1—brain cancer	5.36e-06	9.39e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CTNNB1—brain cancer	5.36e-06	9.39e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CTNNB1—brain cancer	5.31e-06	9.3e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TP53—brain cancer	5.3e-06	9.29e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TP53—brain cancer	5.08e-06	8.9e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—VEGFA—brain cancer	4.75e-06	8.32e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—VEGFA—brain cancer	4.73e-06	8.29e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—VEGFA—brain cancer	4.72e-06	8.27e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—STAT3—brain cancer	4.7e-06	8.24e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—STAT3—brain cancer	4.69e-06	8.21e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—VEGFA—brain cancer	4.67e-06	8.19e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—STAT3—brain cancer	4.67e-06	8.19e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—STAT3—brain cancer	4.62e-06	8.11e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MYC—brain cancer	4.37e-06	7.66e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MYC—brain cancer	4.35e-06	7.63e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MYC—brain cancer	4.34e-06	7.61e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MYC—brain cancer	4.3e-06	7.53e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—EGFR—brain cancer	4.27e-06	7.49e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—EGFR—brain cancer	4.26e-06	7.46e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—EGFR—brain cancer	4.24e-06	7.44e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—EGFR—brain cancer	4.2e-06	7.37e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CG—brain cancer	3.69e-06	6.46e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TP53—brain cancer	3.59e-06	6.29e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TP53—brain cancer	3.58e-06	6.27e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TP53—brain cancer	3.56e-06	6.25e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TP53—brain cancer	3.53e-06	6.19e-05	CbGpPWpGaD
